Related Experiment Video
Updated: Jun 5, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Immunogenicity of single dose live attenuated hepatitis a vaccine
Sheila Bhave1, Ashish Bavdekar, Amita Sapru
1Department of Pediatrics, KEM Hospital, Pune 411 011, India.
Abstract:
A long-term immunogenicity study of a single dose live attenuated H2 strain hepatitis A vaccine is being conducted in healthy Indian children at KEM Hospital, Pune. 131 of the original 143 children vaccinated in 2004, were evaluated for anti-HAV antibodies 30 months post vaccination (2007). Seroprotective antibody levels >20 mIU/mL were demonstrated in 87.8 % subjects with an overall GMT of 92.02 mIU/mL. No hepatitis like illness was recorded in any of the subjects since vaccination.
More Related Videos
Related Concept Videos
Vaccines
Vaccinations

